2020 SIDP Annual Meeting (BCIDP+ACPE Credit): Early Antifungals in the ICU: Untangling the Unnecessarily Complex; Antibiotic De-escalation: Preventing Resistance or Futile Existence?

This includes two activities from the 2020 SIDP Annual Meeting that are available on-demand for home-study BCIDP+ACPE Credit. SIDP Members: visit https://sidp.org/MbrRate for member pricing.

A Review in the Treatment Options for Renal Cell Cancer

This activity will review treatment options for patients with RCC. The pharmacological treatments available, appropriate use, adverse events, monitoring of agents, and management of adverse events will also be discussed. Available for free to NASP members. Visit www.ProCE.com/CSPE for details.

A Specialty Pharmacy Pipeline Product Update

An update on what is in the pipeline is the focus of this presentation. The most recent approvals and near-term products will be covered. Available for free to NASP members-visit www.ProCE.com/CSPE

Addressing Risks Associated with IV Push Medication Use in Adults

Experts will address the variability of practice with IV push medication use, including unnecessary unit-based preparation and dilution and unsafe injection practices, highlighting strategies necessary for the mitigation of risk.

Adherence Concepts for the Cancer Patient

This activity addresses the issue of adherence in the oncology patient. Topics include the incidence, reasons and consequences of non-adherence. Strategies to remove barriers to non-adherence and improve adherence rates will be discussed. Available for free to NASP members-visit www.ProCE.com/CSPE

Adult Vaccines in 2018: Where Do We Start?

Vaccines are an important aspect of public health, and this activity will seek to broaden the conversation about preventative health and how immunizations fit into pharmacy practice.

Advancing Personalized Treatment of Patients with Hemophilia Through Comprehensive Pharmacokinetic Assessment

This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.

An Introduction to Gene and Disease-modifying Therapies in Specialty Pharmacy

This activity will briefly review key background information and definitions and then discuss gene therapy, disease-modifying treatments and patient considerations following therapy. Available for free to NASP members. Visit www.ProCE.com/CSPE for details.

Antibiotic De-escalation: Preventing Resistance or Futile Existence?

Expert faculty will debate the pros and cons of Antibiotic De-escalation. Primary literature and guidelines recommendations regarding de-escalation and antibiotic resistance will frame the basis for this discussion as best practices are identified.

Antimicrobial Resistance in the times of COVID-19

This webinar will describe the epidemiology of multi-drug resistant organisms in Latin America prior to the COVID-19 pandemic, and review the ramifications of the pandemic with regards to antibiotic misuse and overuse in Latin America.